Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Semela

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Plos One|June 25, 2015
Modeling the Health and Economic Burden of Hepatitis C Virus in SwitzerlandBeat Müllhaupt, Philip Bruggmann, Florian Bihl, et al.
Medical Ultrasonography|December 27, 2023
Ultrasound Doppler technique for the diagnosis of focal nodular hyperplasia - case series and systematic reviewMikael Sawatzki, Thomas Burkart, Stephan Baumeler, et al.
Journal of Hepatology|February 27, 2007
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinomaDavid Semela, Anne-Christine Piguet, Mirjam Kolev, et al.
Swiss Medical Weekly|January 24, 2019
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regionsUrs Rusch, Sarah Robbins, Homie Razavi, et al.
Journal of Cell Science|January 26, 2007
Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2Ningling Kang-Decker, Sheng Cao, Suvro Chatterjee, et al.
Swiss Medical Weekly|April 10, 2026
Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysisMirjam Kolev, Salomé Wolf, Elizabeth Petràš, et al.
Journal of Hepatology|July 23, 2017
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre studyPhilippe Kolly, Oliver Waidmann, Johannes Vermehren, et al.
Plos One|January 1, 2019
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?Beat Müllhaupt, Philip Bruggmann, Florian Bihl, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Constitutive Notch2 signaling induces hepatic tumors in miceMichael T Dill, Luigi Tornillo, Thorsten Fritzius, et al.
Journal of Viral Hepatitis|August 8, 2023
Assessing the hepatitis C epidemiology in Switzerland: It's not that trivialSarah Blach, Andrea Bregenzer, Philip Bruggmann, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Plos One|June 25, 2015
Modeling the Health and Economic Burden of Hepatitis C Virus in SwitzerlandBeat Müllhaupt, Philip Bruggmann, Florian Bihl, et al.
Medical Ultrasonography|December 27, 2023
Ultrasound Doppler technique for the diagnosis of focal nodular hyperplasia - case series and systematic reviewMikael Sawatzki, Thomas Burkart, Stephan Baumeler, et al.
Journal of Hepatology|February 27, 2007
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinomaDavid Semela, Anne-Christine Piguet, Mirjam Kolev, et al.
Swiss Medical Weekly|January 24, 2019
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regionsUrs Rusch, Sarah Robbins, Homie Razavi, et al.
Journal of Cell Science|January 26, 2007
Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2Ningling Kang-Decker, Sheng Cao, Suvro Chatterjee, et al.
Swiss Medical Weekly|April 10, 2026
Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysisMirjam Kolev, Salomé Wolf, Elizabeth Petràš, et al.
Journal of Hepatology|July 23, 2017
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre studyPhilippe Kolly, Oliver Waidmann, Johannes Vermehren, et al.
Plos One|January 1, 2019
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?Beat Müllhaupt, Philip Bruggmann, Florian Bihl, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Constitutive Notch2 signaling induces hepatic tumors in miceMichael T Dill, Luigi Tornillo, Thorsten Fritzius, et al.
Journal of Viral Hepatitis|August 8, 2023
Assessing the hepatitis C epidemiology in Switzerland: It's not that trivialSarah Blach, Andrea Bregenzer, Philip Bruggmann, et al.
Pageof 10